Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Merce Barenys"'
Autor:
Alfredo J. Lucendo, Stephan Miehlke, Christoph Schlag, Michael Vieth, Ulrike von Arnim, Javier Molina-Infante, Dirk Hartmann, Albert Jan Bredenoord, Constanza Ciriza de los Rios, Stefan Schubert, Stefan Brückner, Ahmed Madisch, Jamal Hayat, Jan Tack, Stephen Attwood, Ralph Mueller, Roland Greinwald, Alain Schoepfer, Alex Straumann, Tim Vanuytsel, Hubert Louis, Carmen Musala, Dorothea Frederking, Monther Bajbouj, Simon Nennstiel, Renate Schmelz, Schmelz Heimerl, Anna-Magdalena Stephan, Christiane Fibbe, Niels Liedtke (née Laschinsky), Jutta Keller, Ulrich Rosien, Sebastian Haag, Arne Schneider, Christoph Schmöcker, Hendrik Buchholz, Frank Lammert, Markus Casper, Matthias Reichert, Dirk Sommer, Hubert Mönnikes, Miriam Stengel, Marco Schmidtmann, Michaela Müller, Alexander Eckardt, Till Wehrmann, Peter Armerding, Wolf Peter Hofmann, Thomas Liceni, Arne Kandulski, Jochen Weigt, Norbert Börner, Anne Lutz-Vorderbrügge, Jörg Albert, Stefan Zeuzem, Irina Blumenstein, Kathrin Sprinzl, Johannes Hausmann, Arjan Bredenoord, Marijn Warners, Alfredo Lucendo Villarin, Ángel Arias Arias, Maria Ángeles Tejero Bustos, María Jesús Carrillo Ramos, José María Olalla Gallardo, Rocío Juárez Tosina, José Zamorano, Cecilio Santander Vaquero, Sergio Casabona Francés, Teresa Pérez, Teresa Rodriguez, Constanza Ciriza de los Ríos, Fernando Canga Rodríguez-Valcárcel, Isabel Castel de Lucas, Antonia Perelló Juan, Merce Barenys, Carlos Pons, Isabel Perez Martinez, M. Eugenia Lauret, Andrés Castaño García, Esmeralda Rubio, Petr Hruz, Simon Brunner, Andrew Poullis
Publikováno v:
Gastroenterology, 157(1), 74-86.e15. W.B. Saunders Ltd
BACKGROUND & AIMS: Swallowed topical-acting corticosteroids are recommended as first-line therapy for eosinophilic esophagitis (EoE). Asthma medications not optimized for esophageal delivery are sometimes effective, although given off-label. We perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31b8a18c7e478ffb6a8967996b658598
https://lirias.kuleuven.be/handle/123456789/637222
https://lirias.kuleuven.be/handle/123456789/637222
Autor:
María Caldas, Ángeles Pérez-Aisa, Manuel Castro-Fernández, Luis Bujanda, Alfredo J. Lucendo, Luis Rodrigo, Jose M. Huguet, Jorge Pérez-Lasala, Javier Molina-Infante, Jesús Barrio, Luis Fernández-Salazar, Ángel Lanas, Mónica Perona, Manuel Domínguez-Cajal, Juan Ortuño, Blas José Gómez-Rodríguez, Pedro Almela, Josep María Botargués, Óscar Núñez, Inés Modolell, Judith Gómez, Rafael Ruiz-Zorrilla, Cristóbal De la Coba, Alain Huerta, Eduardo Iyo, Liliana Pozzati, Rosario Antón, Mercé Barenys, Teresa Angueira, Miguel Fernández-Bermejo, Ana Campillo, Javier Alcedo, Ramón Pajares-Villaroya, Marianela Mego, Fernando Bermejo, José Luis Dominguez-Jiménez, Llúcia Titó, Nuria Fernández, Manuel Pabón-Carrasco, Ángel Cosme, Pilar Mata-Romero, Noelia Alcaide, Inés Ariño, Tommaso Di Maira, Ana Garre, Ignasi Puig, Olga P. Nyssen, Francis Megraud, Colm O’Morain, Javier P. Gisbert
Publikováno v:
Antibiotics, Vol 10, Iss 1, p 13 (2020)
The management of Helicobacter pylori infection has to rely on previous local effectiveness due to the geographical variability of antibiotic resistance. The aim of this study was to evaluate the effectiveness of first and second-line H. pylori treat
Externí odkaz:
https://doaj.org/article/eb007900cc93448eae4ce947390e1f94
